Landry P, Warnes H, Nielsen T, Montplaisir J
Department of Psychiatry, Hôpital Louis-H. Lafontaine, Montréal, Québec, Canada.
Int Clin Psychopharmacol. 1999 May;14(3):173-5.
The prevalence of somnambulistic-like behaviour related to treatment with lithium alone or in combination with other psychotropic medications was evaluated in patients attending a lithium clinic. A written questionnaire on somnambulistic-like behaviour was completed by 389 patients. Information was provided on the time of occurrence, frequency and severity of the episodes, the presence of childhood somnambulism, and the temporal relationship between psychiatric treatment and somnambulistic-like behaviour. Twenty-seven (27) patients (6.9%) presented sleepwalking behaviour related to the onset of treatment with lithium alone or in combination with other psychotropic drugs. Forty-five patients (11.6%) reported childhood somnambulism and 12 of them (27%) had their childhood somnambulism reactivated by the medication. Most patients had a diagnosis of bipolar affective disorder but somnambulistic-like behaviour also occurred in patients with other axis 1 diagnosis. Sleep-related violence was seldomly reported. Therefore, lithium alone or in combination with other psychotropic drugs may induce somnambulistic-like behaviour. A history of childhood somnambulism may increase the risk of developing sleepwalking behaviour while under psychotropic drugs treatment.
在一家锂盐诊所就诊的患者中,评估了单独使用锂盐或与其他精神药物联合使用时出现的类梦游行为的发生率。389名患者填写了一份关于类梦游行为的书面问卷。问卷提供了发作时间、发作频率和严重程度、儿童期梦游情况,以及精神治疗与类梦游行为之间的时间关系等信息。27名(6.9%)患者出现了与单独使用锂盐或与其他精神药物联合治疗开始相关的梦游行为。45名患者(11.6%)报告有儿童期梦游,其中12名(27%)患者的儿童期梦游因药物治疗而复发。大多数患者被诊断为双相情感障碍,但类梦游行为也发生在其他轴I诊断的患者中。很少有与睡眠相关的暴力行为报告。因此,单独使用锂盐或与其他精神药物联合使用可能会诱发类梦游行为。儿童期梦游史可能会增加在精神药物治疗期间出现梦游行为的风险。